SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-010677
Filing Date
2024-04-10
Accepted
2024-04-10 20:37:20
Documents
2
Period of Report
2024-04-08

Document Format Files

Seq Description Document Type Size
1 form3-04112024_120413.html 3  
1 form3-04112024_120413.xml 3 4505
2 ex24-04112024_120414.htm EX-24 5509
  Complete submission text file 0001415889-24-010677.txt   11508
Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE CA 94085
Business Address
Kunkel Lori Anne (Reporting) CIK: 0001536368 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39247 | Film No.: 24836934

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Issuer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)